Thrombin is a serine protease that plays a crucial role in the blood coagulation cascade. It is responsible for converting soluble fibrinogen into insoluble fibrin, which forms the basis of a blood clot. Thrombin also activates various coagulation factors, including factors V, VII, VIII, XI, and XIII, and plays a role in platelet activation, inflammation, and wound healing .
Recombinant thrombin is produced using recombinant DNA technology, which involves inserting the gene encoding human thrombin into a host cell, such as Escherichia coli or Chinese hamster ovary (CHO) cells. This method allows for the production of highly purified thrombin without the risk of contamination from human plasma-derived products .
In one study, researchers successfully expressed and purified human activated thrombin in a prokaryotic system using E. coli. The thrombin was fused with a 6×his-tag and purified using Ni²⁺-NTA affinity chromatography. The purified protein underwent air oxidation for proper refolding and was characterized by SDS-PAGE analysis, western blotting, and bioactivity assays .
Thrombin has several key biological functions:
Recombinant thrombin is used in various clinical settings to control bleeding. It is particularly useful in surgeries where traditional methods of hemostasis, such as sutures or cautery, are ineffective or impractical. Recombinant thrombin is available under several brand names, including Artiss, Evarrest, Evicel, Evithrom, Tachosil, Tisseel, and Vistaseal .
The use of recombinant thrombin offers several advantages over plasma-derived thrombin: